Prakash A Jacob, Surendra K Sai, Lakshmi M Vijaya, Shetty VishwaPrakash, Jogi Reddy M Murali, Thomas Vara Joy
Department of Oral and Maxillofacial Pathology, Lenora Institute of Dental Sciences, Andhra Pradesh, India.
Oral and Maxillofacial Pathologist in Holy Family Multispecialty Dental Clinic, Tuni, Andhra Pradesh, India.
J Cancer Res Ther. 2023 Jul-Sep;19(5):1170-1175. doi: 10.4103/jcrt.JCRT_545_21.
Oral cancers are often detected at late stages, and patients usually had a 50% chance of a 5-year survival rate. Oral cancer usually has an early precancerous stage before its actual malignant transformation. Although there are various approaches to diagnose the early stages of cancer, there is one less explored, cost-effective, and simple technique known as the crystallization test. The aim of the study was to evaluate the crystallization patterns in tobacco users, oral potentially malignant disorders (OPMDs), and oral malignancies.
Fifteen patients with oral malignancies, 15 patients with oral potentially malignant disorders, 15 tobacco users, and 15 healthy individuals participated in the crystallization test. Single blood drop was used to perform this test and the obtained crystal patterns were analyzed.
This test had a sensitivity of 93.3%, 80.0%, and 20.0% for oral malignancies, oral Potentially Malignant Disorders (PMDs), and tobacco users, respectively. Chi-square analysis revealed a highly significant transverse form between OPMDs and oral malignancies (P < 0.05).
Crystallization test was found to be a sensitive, reliable, economical, and less invasive procedure for screening of oral PMDs and oral malignancies under strictly maintained physical conditions.
口腔癌通常在晚期才被发现,患者的5年生存率通常为50%。口腔癌在实际发生恶性转化之前通常有一个早期癌前阶段。尽管有多种方法可用于诊断癌症的早期阶段,但有一种较少被探索、经济高效且简单的技术,即结晶试验。本研究的目的是评估烟草使用者、口腔潜在恶性疾病(OPMD)和口腔恶性肿瘤中的结晶模式。
15例口腔恶性肿瘤患者、15例口腔潜在恶性疾病患者、15名烟草使用者和15名健康个体参与了结晶试验。使用单滴血液进行该试验,并对获得的晶体模式进行分析。
该试验对口腔恶性肿瘤、口腔潜在恶性疾病(PMD)和烟草使用者的敏感性分别为93.3%、80.0%和20.0%。卡方分析显示,OPMD与口腔恶性肿瘤之间存在高度显著的横向形式(P < 0.05)。
在严格维持的物理条件下,结晶试验被发现是一种用于筛查口腔PMD和口腔恶性肿瘤的敏感、可靠、经济且侵入性较小的程序。